Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Patrick McCormick

Neurological Surgery Toledo, OH Medical Doctor

NPI 1124021514 CMS profile 141201

2222 Cherry St, Ste M200, Toledo, OH 43608

Open in the dashboard

General payments

$1,154

16 records reported · program years 2019–2025

Research payments

$850

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$15,337 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Patrick McCormick of Toledo, OH is reported in the CMS Open Payments database as having received $1,154 across 16 general payments and $850 in research payments paid to them. Separately, studies naming them as principal investigator received $15,337 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 42nd percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $115 3
2024 General $50 3
2023 General $29 2
2022 General $20 1
2020 General $17 1
2019 General $923 6
2019 Research $850 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Patrick McCormick
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Patrick McCormick were reported at $115. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Patrick McCormick Neurological Surgery median Middle half National median
2019 $923 $582 $138–$3,006 $163
2020 $17 $294 $76–$2,174 $114
2021 $0 $387 $105–$2,432 $132
2022 $20 $542 $139–$2,989 $149
2023 $29 $534 $145–$2,697 $160
2024 $50 $574 $155–$3,046 $164
2025 $115 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Globus Medical, Inc. $749 4 payments
  2. Stryker Corporation $158 1 payment
  3. Medtronic, Inc. $120 7 payments
  4. Intrinsic Therapeutics $74 1 payment
  5. Alexion Pharmaceuticals, Inc. $20 1 payment
  6. Innovation Technologies Inc $17 1 payment
  7. Zimmer Biomet Holdings, Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $684 2 payments
  2. Food and Beverage $470 14 payments
Products named General payments · program years 2019–2025
  1. RISE $567 2 payments
  2. Excelsius - GPS $182 2 payments
  3. TRITANIUM $158 1 payment
  4. CATALYFT PL EXPANDABLE INTERBODY SYSTEM $75 4 payments
  5. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $74 1 payment
  6. BARRICAID ACD (ANNULAR CLOSURE DEVICE) Annular Closure Device $74 1 payment
  7. CD HORIZON SPINAL SYSTEM $31 2 payments
  8. ANDEXXA $20 1 payment
  9. Irrisept $17 1 payment
  10. Walter $16 1 payment
  11. Other $14 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Biogen, Inc. $850 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

206

Median for Neurosurgery: 83

Drug cost

$1,858

Median for Neurosurgery: $872

Branded share of claims

29.6%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Gabapentin Generic 78 $814
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 46 $525
Tizanidine Hcl Generic 29 $183
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 15 $125
Oxycodone Hcl Generic 12 $101
Diazepam Generic 13 $66
Tramadol Hcl Generic 13 $46

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 27 billing codes

Paid by Medicare

$128,747

Medicare's payments for the services billed

Medicare patients

181

Average age 73

Services billed

417

94 women, 87 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 30%
Ischemic heart disease 27%
Depression 23%
Chronic kidney disease 22%
Cancer 19%
Osteoporosis 18%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

17 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Neurological Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record